B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 11.13 USD -0.27% Market Closed
Market Cap: 901.2m USD
Have any thoughts about
Bioventus Inc?
Write Note

Bioventus Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioventus Inc
Cost of Revenue Peer Comparison

Comparables:
HAE
ICUI
ALGN
LNTH
MMSI

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioventus Inc
NASDAQ:BVS
Cost of Revenue
-$184.2m
CAGR 3-Years
-28%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Cost of Revenue
-$625.9m
CAGR 3-Years
-8%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
ICU Medical Inc
NASDAQ:ICUI
Cost of Revenue
-$1.6B
CAGR 3-Years
-24%
CAGR 5-Years
-14%
CAGR 10-Years
-26%
Align Technology Inc
NASDAQ:ALGN
Cost of Revenue
-$1.2B
CAGR 3-Years
-8%
CAGR 5-Years
-13%
CAGR 10-Years
-21%
Lantheus Holdings Inc
NASDAQ:LNTH
Cost of Revenue
-$527.2m
CAGR 3-Years
-34%
CAGR 5-Years
-25%
CAGR 10-Years
-11%
Merit Medical Systems Inc
NASDAQ:MMSI
Cost of Revenue
-$705m
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-10%

See Also

What is Bioventus Inc's Cost of Revenue?
Cost of Revenue
-184.2m USD

Based on the financial report for Dec 31, 2023, Bioventus Inc's Cost of Revenue amounts to -184.2m USD.

What is Bioventus Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-17%

Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for Bioventus Inc have been -28% over the past three years , -17% over the past five years .

Back to Top